MedPath
TGA Approval

DBL NALOXONE HYDROCHLORIDE 400 microgram/1mL injection USP ampoule (16282)

16282

DBL NALOXONE HYDROCHLORIDE 400 microgram/1mL injection USP ampoule

Pfizer Australia Pty Ltd

October 8, 1991

Medicine

Medicine

Active

Registered

Product Information

Consumer Medicine Information

http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2018-CMI-01864-1

Product Information

http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2018-PI-01863-1

Active Ingredients

naloxone hydrochloride dihydrate

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

DBL NALOXONE HYDROCHLORIDE 400 microgram/1mL injection USP ampoule (16282) - TGA 批准文号 | MedPath